China has cut value-added tax (VAT) to 3% on imports, production and sales of the second batch of anti-cancer and rare diseases drugs in a bid to lower costs for patients and boost its pharmaceutical industry, customs said on Thursday.
Source: todayonline.com
Latest Posts in "China"
- Trickiest countries in which to achieve compliance
- China Lowers Luxury Car Tax Threshold to CNY 900,000, Expanding Tax Scope from July 2025
- China Revises VAT Rebate Policy 2025: Full Refunds for Key Industries, Partial for Others
- China Clarifies Tax Reporting Rules for Digital Platforms, Effective October 1, 2023
- France Cracks Down on Chinese E-Commerce Giants with Fines and Regulations
